Engflag

Asytec

Quick links to important sections

Asytec

Asytec_EN

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Asytec

Quick Facts

Property Description
Active Ingredient Cetirizine Hydrochloride (Cetirizine HCl)
Form Tablets, Oral Solution, Syrup (typical forms)
Pharmacological Class Second-generation Antihistamine (H1 Receptor Antagonist)
General Purpose Symptomatic relief of allergic conditions
Origin Synthetic (Piperazine derivative)

What Type of Medicine is Asytec?

Asytec is a trade name for a pharmaceutical product containing the active ingredient Cetirizine, which is classified as a second-generation antihistamine and a selective H1 receptor antagonist. This medicine is a synthetic compound derived from the piperazine chemical family. Pharmacological studies have supported that second-generation agents, including Cetirizine, are designed for peripheral selectivity, meaning they predominantly act on receptors located outside the central nervous system. This molecular refinement is a key differentiator, as it helps mitigate the generalized sedation often associated with older antihistamine classes.

Composition and Available Forms of Cetirizine

The active component in Asytec is Cetirizine Hydrochloride (Cetirizine HCl), formulated as the dihydrochloride salt for stable oral administration. The product is a single-entity product, containing only Cetirizine as the core therapeutic ingredient, which is supplied as a racemic mixture. Asytec (Cetirizine) is commonly found in various oral dosage forms, including standard tablets, orally disintegrating tablets, and liquid preparations such as oral solution or syrup. Availability in these forms provides flexibility for use across different patient needs and age groups.

General Purpose and Action of This Antihistamine

The core function of this medication is to provide symptomatic relief for the manifestations of various allergic conditions. Its action is achieved through H1 receptor antagonism, which involves blocking the action of histamine, a chemical mediator released by the body during an allergic response. By preventing histamine from binding to the H1 receptors, the medicine interrupts the chain reaction that causes swelling, itching, and secretions, thereby easing common allergic discomforts, such as persistent sneezing or an itchy, runny nose.

Regulatory References

  1. Cetirizine: MedlinePlus Drug Information

What side effects are possible with Asytec?

Possible Side Effects and Safety Information

Adverse reactions associated with Cetirizine (Asytec) are classified based on frequency as documented in official regulatory documents. The most frequently observed effects generally involve the central nervous system and general systemic disorders, and they are usually mild to moderate. Safety classifications utilize standard terminology, such as Common, Uncommon, Rare, and Very Rare, to define the probability of occurrence based on clinical trial and post-marketing data.

The most prevalent adverse reactions listed in regulatory safety profiles are classified as Common. These include somnolence (drowsiness), headache, fatigue, and dry mouth.

Documented Adverse Reaction Frequencies

Classification Example Adverse Reactions (SOC)
Common Somnolence, Headache, Fatigue, Dry Mouth
Uncommon Agitation, Pruritus, Rash, Diarrhoea
Rare Hypersensitivity, Convulsions, Tachycardia, Abnormal Hepatic Function (reversible)
Very Rare Anaphylactic Shock, Thrombocytopenia, Oculogyric Crisis

Specific Safety Considerations

The regulatory profile also addresses rare but clinically significant events and constraints for specific patient groups. Anaphylactic shock and Abnormal Hepatic Function (elevated enzymes) are documented as serious, though rare or very rare, adverse reactions from post-marketing reports. The label notes that caution is required in patients with predisposing factors for urinary retention, and special consideration is given to patients with impaired renal function and older adults due to potentially altered clearance. Concurrent use with alcohol or CNS depressants may increase the risk of reduced alertness. Additionally, the regulatory profile documents cases of new or worsened itching (pruritus) upon the discontinuation of long-term use.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose involving Asytec (Cetirizine Hydrochloride) is officially documented to primarily affect the Central Nervous System (CNS), often observed after ingestion of doses significantly exceeding the recommended amount. The clinical presentation commonly involves signs of CNS depression, such as marked somnolence, sedation, fatigue, and dizziness. Conversely, some individuals, particularly in the pediatric population, may initially experience signs of agitation and restlessness.

Severe or life-threatening manifestations documented in the regulatory profile include the risk of convulsions and progression to coma. Other documented systemic signs may include tachycardia (fast heart rate) and anticholinergic effects like urinary retention.

In the event of a suspected overdose, official regulatory guidance mandates that individuals seek medical help or contact a Poison Control Center right away. Management is defined as symptomatic and supportive treatment provided by healthcare professionals, as there is no known specific antidote to Cetirizine. Procedures such as gastric lavage or the use of activated charcoal may be considered in the clinical setting following a massive ingestion.

Therapeutic Uses of Asytec

What Asytec Treats: Main Uses and Benefits

Asytec (Cetirizine) is used to provide symptomatic relief across several key allergic domains. This medication is applicable in conditions characterized by episodic or fluctuating manifestations and is relevant when supportive symptom management is appropriate.

The medication is generally used to address symptoms associated with Seasonal Allergic Rhinitis (hay fever), Perennial Allergic Rhinitis, and certain allergic skin conditions such as Chronic Idiopathic Urticaria (hives). This includes addressing symptom clusters that may become intense or disruptive, specifically persistent sneezing and runny nose (rhinorrhea), bothersome itchy, watery eyes, and significant skin discomfort like pruritus and wheals.

“Supportive relief is provided when symptoms interfere with routine activities, contributing to comfort during symptomatic periods.”

Quick Fact: Relief for Nasal and Skin Discomfort

Symptom Domain Key Symptom Relieved Clinical Context
Respiratory/Nasal Sneezing, Rhinorrhea Seasonal or Perennial exposure
Cutaneous Itching (Pruritus), Wheals Chronic Urticaria flare-ups

Providing supportive relief when symptoms interfere with routine activities may assist with maintaining functional stability when symptoms are more noticeable, helping patients cope more steadily with symptom fluctuations.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Ezetimibe — official regulatory information

Eligibility scope

Populations for whom use is allowed (as stated in label):

  • Adults and pediatric patients ge 9 years of age with homozygous familial sitosterolemia (to reduce sitosterol/campesterol levels).
  • Adults and pediatric patients ge 10 years of age with elevated LDL-C for use alone or in combination with a statin/other therapies.

Populations for whom use is contraindicated:

  • Patients with a known hypersensitivity to Ezetimibe or any component of the drug product.
  • When used in combination with a statin, the combined use is contraindicated in patients for whom the statin itself is contraindicated (e.g., active liver disease, pregnancy).

Age-related eligibility rules:

  • Pediatric use is established for those 9 years of age and older for sitosterolemia, and 10 years of age and older for hypercholesterolemia.

Condition-specific eligibility rules:

  • Patients should be assessed for liver enzyme abnormalities as clinically indicated.

Eligibility classifications (high-level)

Eligibility severity classification (as defined in official documents):

  • Contraindicated (for hypersensitivity and for combination use when the co-administered drug is contraindicated).

Regulatory basis (EMA / FDA / etc.):

  • FDA (U.S. Approval).

Eligibility-context constraints (as defined in official documents):

  • Coadministration with fibrates, other than fenofibrate, is generally not recommended until further study.

Resulting eligibility structure

Official eligibility statements:

  • Use is allowed for pediatric patients (age ge 9 or ge 10) and adults for specific lipid disorders.
  • Ezetimibe is contraindicated if the patient has a known hypersensitivity to the drug.
  • When combining Ezetimibe with another drug (like a statin), the contraindications of the partner drug apply to the combination regimen.

Connection to the overall eligibility profile (2–4 sentences): The regulatory profile strictly defines eligible use for adults and older pediatric patients with specific elevated lipid levels, including those with genetic disorders. The primary constraints are standard hypersensitivity and a unique restriction based on the co-administered drug: if Ezetimibe is used with a statin, the patient must not have any contraindications for that statin (such as active liver disease). Use is therefore contingent on the patient's individual condition and the profile of any drug prescribed alongside it.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interactions with Asytec (Cetirizine Hydrochloride) are officially documented in regulatory information across several key domains, focusing primarily on additive effects and changes in the medicine's processing by the body.

Pharmacodynamic and Exposure Interactions

Type of Interaction Interacting Substance/Condition Regulatory Finding
Pharmacodynamic Alcohol or CNS Depressants Potential for additive effects, leading to further reduction in alertness and performance impairment.
Pharmacokinetic Theophylline (400 mg once daily) Documented 16% decrease in Cetirizine clearance, increasing exposure.
Absorption/Food Food Does not reduce the extent of absorption but may delay the rate of absorption.

General Interaction Profile

The regulatory profile confirms that Cetirizine is only minimally metabolized and is not a major substrate of the CYP450 system, which minimizes the risk of many enzyme-mediated drug interactions. Studies showed no clinically significant interactions with medicines such as pseudoephedrine, azithromycin, or erythromycin. No medicinal product combinations are formally classified as contraindicated due to interaction risk in the primary regulatory documents.

Population-Specific Considerations

Official labeling notes that clearance is reduced in renal impairment and potentially in hepatic impairment, leading to prolonged elimination. A prolonged half-life and lower total body clearance are also observed in geriatric patients.

Mechanism of Action

Blocking the Histamine Signal (H1-Receptor Antagonism)

Asytec's primary action involves acting as a targeted antagonist (blocker) that engages with the histamine H1-receptors on cell surfaces. By occupying these receptor sites, the drug effectively stops the key inflammatory molecule histamine from binding and triggering the initial signaling cascade, which results in the modulation of cell activity following histamine release.

Stabilizing Inflammatory Cells and Mediators

The drug also exerts a direct, stabilizing effect on immune cells like mast cells and basophils. This mechanism inhibits their ability to release an array of pro-inflammatory chemicals beyond histamine, such as leukotrienes and kinins. This second line of action results in the modulation of the downstream effects of the acute inflammatory cascade, which alters the factors governing local vasodilation and capillary permeability.

Dosage and Administration Information

How to Use Asytec: Administration Guidelines

Asytec (Cetirizine) is used according to specific dosing and administration guidelines. The medicine is primarily administered through the oral route as tablets or solution for systemic use. It is typically taken once daily, establishing a simple 24-hour dosing interval for patient adherence. The maximum daily dose for adults and children over 6 years is consistently defined as 10 mg.

Administration Scope

Feature Standard Parameters
Route of Administration Oral (tablets/solution); Intravenous (IV) injection; Ophthalmic solution (local use)
Standard Dosing Regime 5 mg or 10 mg taken once daily for adults and children 6 years.
Timing in relation to meals Oral forms may be taken with or without food, providing intake flexibility.
Frequency Predominantly Once daily (every 24 hours).

Population-Specific Use

Prescribing information includes dose adjustments for certain patient populations. For adults with moderate to severe renal impairment, the dose is reduced to 5 mg once daily. Children aged 2 to 5 years may be administered 2.5 mg once daily or in two divided doses of 2.5 mg every 12 hours. Additionally, the IV injection for acute use is administered undiluted as a controlled intravenous push over 1 to 2 minutes.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Asytec

The research evidence for Asytec (Cetirizine) comes primarily from formal clinical evaluations, including randomized controlled trials (RCTs) and comprehensive meta-analyses that compile data from many separate studies. This overview describes what the research has examined, what the findings suggest, and where certainty remains low.

Evidence for Use in Seasonal Allergic Rhinitis (Hay Fever)

Research exploring how symptoms change over time in seasonal allergies primarily involves short-term, double-blind RCTs and controlled exposure studies. These studies typically last between two and six weeks. The populations studied included adults, adolescents, and children over the age of two. Research examined patient-reported outcomes describing physical discomfort, focusing on the Total Symptom Score Complex (TSSC). Comparative studies also explored how these measured changes compared to a placebo (an inactive treatment).

Evidence for Use in Perennial Allergic Rhinitis

For perennial allergic rhinitis—conditions where symptoms may vary in intensity due to year-round exposure—the evidence is derived from studies observing responses over defined time intervals, usually intermediate-term trials lasting around four weeks. The evidence landscape includes numerous, well-aligned studies for this indication. The main study outcomes examined were the measured changes in persistent symptoms and measured changes in patient-reported Quality of Life scores related to the condition.

Key Research Gaps and Uncertainties

A significant limitation is that long-term outcomes for all indications are not fully established by high-quality, multi-year RCTs. Follow-up durations were often limited to short or intermediate periods. Data for certain groups, particularly older adults or patients with severe pre-existing health conditions, are often limited in the main body of the RCT evidence. Furthermore, research does not determine whether an individual will respond similarly to the group patterns observed in trials.

Key Studies & References Efficacy of cetirizine for seasonal allergic rhinitis: A meta-analysis of randomized controlled trials

Frequently Asked Questions (FAQ)

Common questions about Asytec (FAQ)

Q: What is Asytec, and what is it used for?

A: Asytec is a prescription medication used to treat certain conditions. It belongs to a class of drugs that works by targeting specific processes in the body to manage symptoms or slow the progression of the condition. Your healthcare provider determines if this medication is appropriate for your specific diagnosis.

Q: How should I take Asytec?

A: You should take Asytec exactly as your doctor prescribes. This usually involves taking the tablet by mouth, with or without food, at the same time each day to maintain consistent levels of the medication in your body. Do not crush, chew, or break the tablets unless your doctor or pharmacist tells you to.

Q: What should I do if I miss a dose of Asytec?

A: If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and return to your regular dosing schedule. Do not take two doses at the same time to make up for a missed dose. If you are unsure what to do, contact your healthcare provider or pharmacist for guidance.

Q: What are the common side effects of Asytec?

A: Common side effects of Asytec may include:

  • Fatigue or feeling tired
  • Nausea or stomach upset
  • Headache
  • Changes in blood cell counts
  • Changes in liver function tests

These side effects are often mild. Tell your doctor about any side effects you experience, especially if they are severe or do not go away.

Q: What are the serious side effects of Asytec I should watch for?

A: Serious side effects, while rare, can occur and may require immediate medical attention. Call your doctor right away or seek emergency care if you experience any of the following:

  • Signs of a severe allergic reaction, such as rash, hives, swelling of the face, lips, tongue, or throat, or difficulty breathing.
  • Signs of severe liver problems, such as yellowing of the skin or eyes (jaundice), dark urine, or pain in the upper right side of your stomach area.
  • Unusual bleeding or bruising.
  • Fever or other signs of infection.

Q: Can I take other medications with Asytec?

A: Before starting Asytec, tell your healthcare provider about all the medications you take, including prescription and over-the-counter drugs, vitamins, and herbal supplements. Certain medications can interact with Asytec, potentially affecting how it works or increasing the risk of side effects. Your doctor may need to adjust the dose of Asytec or your other medicines.

Q: What if I am pregnant or breastfeeding while taking Asytec?

A: Asytec is generally not recommended for use during pregnancy as it may harm the fetus. If you are pregnant, plan to become pregnant, or become pregnant while taking this drug, discuss the potential risks and benefits with your doctor. It is also not known if Asytec passes into breast milk, so discuss safe feeding options with your healthcare provider if you are breastfeeding.

How should Asytec be stored and disposed of?

How to Store and Dispose of Asytec?

Asytec (Cetirizine Hydrochloride) must be stored strictly according to the conditions documented in official regulatory labeling to ensure stability and safety.

Required Storage Conditions

Temperature: Store the product at 20 C to 25 C (68 F to 77 F), which is the USP Controlled Room Temperature. The medicine must be kept within this range.

Protection: Handling instructions specify the need to protect from light and avoid high humidity, particularly for certain oral formulations.

Handling and Disposal

The most important safety requirement is to keep out of reach of children at all times. Do not use the product if the original container's seal, such as the imprinted foil inner seal or blister unit, is broken or missing, as this indicates compromised integrity. Unused or expired medication must be disposed of in accordance with local regulations for medicinal waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Asytec found in:

A-Z Index: